Managing Partner, Polaris Partners
Academic biotech spinout specialist and innovator
Ellie McGuire is a Managing Partner at Polaris Partners in the Boston office and co-founder of the Polaris Innovation Fund, which invests in early-stage academic biomedical research. She previously was Head of Business Development at Lyndra, and held leadership and consulting roles at Arsia Therapeutics, SQZ Biotechnologies, and XTuit Pharmaceuticals. She is an Expert in Residence for the Harvard Office of Technology Development. She serves on boards of Muna Therapeutics, Montis Biosciences, FOLX Health, and Noema Pharma.
Early-stage biotech companies spun from academic medical centers with the potential to translate breakthrough science into medicines.
Typical check: $300K–$2M
Based in: Boston, MA (North America)